Research in Motion (RIMM)

Size: px
Start display at page:

Download "Research in Motion (RIMM)"

Transcription

1 COMPANY NOTE USA Technology Telecom Equipment/Wireless Research in Motion (RIMM) Limited Patent Value; Cut Target to Salvage Value of $21 as We Wait for QNX Key Takeaway In consultation with industry experts, we performed a deep dive on 1,400 patents to determine the firms with essential LTE patents. We also analyzed the three required smartphone patent areas (Wireless, OS/Software, Hardware). With an on-going handset business, RIM's patent monetization value is likely only $1B, supporting our $21 cash cow salvage valuation (an unlikely scenario but could provide valuation support as we wait for QNX). RIM patents relatively weak: we believe most of RIM's patents are in security rather than in wireless so may have to pay a fair amount in LTE royalties. We believe the liquidation value of RIM's patents is only ~$2.5B. We believe the security patents are worth approximately $500M, RIM s wireless patents are worth approximately $1.2B ($400M LTE plus 3G, etc.), and we add the $770M worth of patents acquired from Nortel. Combining the various patents, we arrive at the patent portfolio value of approximately $2.5B. But with an on-going handset business, RIM's patent monetization likely caps out at ~$1B. In valuing the patents we assume RIM sells its patent portfolio but arranges cross-licensing agreement with other wireless patent holders. The main value would be in licensing the patents to the other third of new and upcoming wireless entrants and in licensing the security patents where RIM is particularly strong and less cross licensing is required. Therefore, we estimate RIM s patents in a take-out could be worth ~$2.5B but likely only ~$1B if RIM still sells handsets. Cash cow salvage value of $21: our analysis is of the scenario whereby the board decides to maximize the value of the cash cow subscription annuity stream while minimizing hardware losses. We give this scenario a low probability as we believe the board is unlikely to challenge the co-ceos. Also, we do not think any buyers are likely to step in; however, we believe the stock is likely to find a bottom around that level. Calculation: net cash ~$1.5B + patents ~$1B - restructuring ~$700M + subscription business. Playbook 2.0 and QNX beta handsets would make us more positive: both should include native /calendar, indicating that the major hurdle for the transition to QNX has been overcome. Management said both should be available in coming months. Valuation/Risks Our $21 target is ~7x our FY13 ests (2-year range 7x-18x). Risks: 1) quicker transition to new OS; 2) stronger new products sales; 3) improved execution. USD Prev. 2010A Prev. 2011A Prev. 2012E Prev. 2013E Rev. (MM) -- 14, , , ,942.0 EV/Rev 0.7x 0.5x 0.6x 0.5x Consensus EPS May A Aug A Nov Feb FY Feb FY P/E 5.2x 3.6x 5.7x 7.1x Financial Summary Price Performance UNDERPERFORM Price target $21.00 (from $25.00) Price $22.73 Net Debt (MM): $(1,415.0) Market Data 52 Week Range: $ $21.60 Total Entprs. Value (MM): $10,497.8 Market Cap. (MM): $11,912.8 Insider Ownership: 11.5% Institutional Ownership: 63.6% Shares Out. (MM): Float (MM): Avg. Daily Vol.: 25,111,962 Peter Misek, CFA, CPA * Equity Analyst (212) pmisek@jefferies.com Jason North * Equity Associate (212) jnorth@jefferies.com Billy Kim * Equity Associate (212) bkim@jefferies.com * Jefferies & Company, Inc. SEP-10 JAN-11 MAY-11 SEP-11 EQUITY RESEARCH AMERICAS Jefferies does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that Jefferies may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see analyst certifications, important disclosure information, and information regarding the status of non-us analysts on pages 10 to 12 of this report.

2 THE LONG VIEW RIMM Research in Motion, Inc. Underperform: $21 Price Target Scenarios Target Investment Thesis Ripple effect of Playbook execution issues leading to QNX delays QNX has integration issues BB OS 7 phones see lackluster sell-through Carrier support flagging Risk to subscriber revenues FY13EPS: $3.21; Target Multiple: 7x; Target Price $21. Upside Scenario BB OS 7 handsets sell better than expected Better execution leads to improved carrier relations QNX phones comes sooner than expected FY13 EPS: $3.50; Target Multiple: 9x; Target Price: $30. Downside Scenario Competition even fiercer than expected leading to ASP and margin erosion QNX phones pushed out FY13 EPS: $3; Target Multiple: 7x Target Price: $18. Long Term Analysis 2-Year Forward P/E 40.0x 30.0x 20.0x 10.0x 0.0x Long Term Financial Model Drivers LT Earnings CAGR 0% Organic Revenue Growth 5% Acquisition Contribution 0% Operating Margin Expansion -5% Other Considerations Ripple effect of Playbook execution issues: our checks indicate the issues have led to a fire drill and resources being pulled off of other projects. We think this will cause QNX delays Forward P/E Upside Target Downside Source: Capital IQ, Jefferies estimates Peer Group Group 2-Year Forward P/Es 30x 25x 20x 15x 10x 5x 0x 12.7x 8.1x 4.6x 27.5x 16.8x Source: Capital IQ, Jefferies estimates 7.6x 8.6x 4.6x Earnings Growth vs 2-Year Forward P/E 60% HTC 40% AAPL 20% DELL MSFT 0% RIMM MMI HPQ -20% NOK -40% 0x 10x 20x 30x Source: Capital IQ, Jefferies estimates Recommendation / Price Target Ticker Rec. PT RIMM Underperform $21 AAPL Buy $500 HTC NC N/A MMI Hold $40 NOK Hold 3.91 HPQ Buy $40 DELL Hold $15 MSFT NC N/A Catalysts Sell-through of BB OS 7 handsets Timing of QNX handsets Signs of enterprise demand for Playbook Company Description Research in Motion designs, manufactures and markets wireless devices, communications solutions and applications globally. The Company is an innovator in the area of wireless technologies and solutions and provides solutions for wireless connectivity to consumers and enterprises around the world. page 2 of 12 Peter Misek, CFA, CPA, Equity Analyst, (212) , pmisek@jefferies.com

3 Proprietary Essential LTE Patent Analysis Please reference our concurrently published industry note Smartphone Patent Wars Far From Over: Deep Dive Into Essential LTE Patents for additional details. In valuing the essential LTE patent portfolios of major players in the wireless space, we utilized outside industry experts that included physics PhDs, wireless engineers, patent legal specialists, and former patent office employees. Our work began by first screening tens of thousands of patents and then determined a level of essentiality based on individually examining over 1,400 patents related to LTE. Patents are difficult to value Most attempts to value patents focus either on 1) counting the total number of patents a company has, but the important number is the number of essential patents, 2) counting the essential patents in the ETSI library, but this data is self-reported. Alternatively, the essentiality of LTE patents can be determined by lawsuit decisions (none yet), licensing agreements, or purchases. Of the latter two, there is no public data apart from the $4.5B purchase of Nortel's patent portfolio. Our methodology for LTE Industry experts performed a proprietary analysis comparing each company s patents to the LTE standards and determined their essentiality. Then we analyzed Nortel's portfolio and estimated how much of the purchase price was likely for the LTE patents. Nortel's patents were in five categories, but we believe about half of the value was in the wireless patents, and that a majority of the wireless value was in the LTE patents. In our LTE patent valuation analysis we assume 30% of the $4.5B acquisition price was for the LTE patents. We note that these values are rough estimates and only for the LTE portion of their portfolios (3G patents will also determine a significant portion of value). Exhibit 1: Essential LTE Patents LG Qualcomm InterDigital Motorola Nokia Samsung ZTE Nortel ETRI TI Ericsson NSN RIM Freescale Huawei NEC 0% 5% 10% 15% 20% 25% Source: Jefferies & Co. page 3 of 12 Peter Misek, CFA, CPA, Equity Analyst, (212) , pmisek@jefferies.com

4 Exhibit 2: Essential LTE Patents: Detail % Ownership of Patent Holder Essential LTE Patents Estimated Value ($M) LG 23% 7,907 Qualcomm 21% 7,329 InterDigital 9% 3,279 Motorola 9% 3,279 Nokia 9% 3,086 Samsung 9% 3,086 ZTE 6% 2,121 Nortel 4% 1,350 ETRI 2% 771 TI 2% 771 Ericsson 2% 579 NSN 2% 579 RIM 1% 386 Freescale 1% 193 Huawei 1% 193 NEC 1% 193 Source: Jefferies & Co. RIM Cash Cow Salvage Valuation JEF: cash cow salvage value for RIM of $21; patents likely only worth ~$1B Our analysis is of the scenario whereby the board decides to maximize the value of the cash cow subscription annuity stream while minimizing hardware losses. We give this scenario a low probability as we believe the board is unlikely to challenge the co-ceos. Also, we do not think any buyers are likely to step in. We assume the hardware business will be run at breakeven and the subscription business will be run as a cash cow. In order to calculate a liquidation value for RIMM, we assume the following Net cash ~$1.5B. Patents monetized for $1B: RIMM has ~2,000 patents in the U.S., ~3,200 in Europe, and ~3,000 in Canada though its share of essential patents is unclear and estimates of RIMM's share of essential LTE patents ranges from 0% to 10%. Overall, we believe RIMM has a solid patent position that is big enough to defray some royalty costs but not all (e.g., RIMM settled with MMI for an upfront payment and on-going fees) and that many of RIMM s stronger patents are in security rather than in wireless. We assume RIMM sells its patent portfolio but arranges cross-licensing agreement with other wireless patent holders. The main value would be in licensing the patents to the other ~33% of new and upcoming wireless entrants. We estimate RIMM s patents in a take-out could be worth ~$2.5B but likely only ~$1B if RIMM still sells handsets. Breakeven hardware business: RIMM aims to run the hardware business at breakeven by gutting R&D and SG&A, ditching QNX, and exiting tablets. Basically, RIMM continue to offer the same messaging-focused handsets at the lowest price possible while remaining cash flow breakeven in the segment. page 4 of 12 Peter Misek, CFA, CPA, Equity Analyst, (212) , pmisek@jefferies.com

5 Annual Subscriber Decline Annual Subscriber Decline Restructuring cash charge of $700M: in this scenario we assume layoffs of 80% of the workforce and severance payments of $50K/person. Subscription business as a cash cow: we assume 80% GM and 54% initial OM for the segment. We run a sensitivity analysis with various churn and ASP decline assumptions to calculate an NPV for the segment. We assume that opex declines in line with subscriber deterioration. Table 1: NPV of Cash Flow from Cash Cow Subscription Business Annual Rate Decline ## 0% 2.5% 5.0% 7.5% 10.0% 0% 13,148 10,250 8,130 6,612 5,514 1% 12,260 9,732 7,835 6,439 5,407 2% 11,333 9,177 7,513 6,248 5,289 3% 10,415 8,611 7,175 6,045 5,162 4% 9,569 8,067 6,835 5,835 5,031 5% 8,820 7,563 6,506 5,623 4,894 6% 8,169 7,106 6,193 5,415 4,757 7% 7,604 6,698 5,904 5,214 4,618 8% 7,116 6,330 5,637 5,024 4,486 9% 6,690 6,003 5,393 4,843 4,352 10% 6,317 5,710 5,169 4,672 4,231 Source: Jefferies The share price calculation then is $1.5B net cash + $1B (patents) - $700M restructuring charge + subscription NPV all divided by 524M shares outstanding. Table 2: Share Price based on Cash Cow Subscription Business Annual Rate Decline 0% 2.5% 5.0% 7.5% 10.0% 0% $28.53 $23.00 $18.95 $16.05 $ % $26.83 $22.01 $18.39 $15.72 $ % $25.06 $20.95 $17.77 $15.36 $ % $23.31 $19.87 $17.13 $14.97 $ % $21.70 $18.83 $16.48 $14.57 $ % $20.27 $17.87 $15.85 $14.17 $ % $19.02 $17.00 $15.25 $13.77 $ % $17.95 $16.22 $14.70 $13.39 $ % $17.02 $15.51 $14.19 $13.02 $ % $16.20 $14.89 $13.73 $12.68 $ % $15.49 $14.33 $13.30 $12.35 $11.51 Source: Jefferies Conclusion A 2.5% annual rate decline and 2% annual subscriber decline implies a $21 stock price. Again, we believe this scenario is unlikely but likely provides some type of floor for the stock. page 5 of 12 Peter Misek, CFA, CPA, Equity Analyst, (212) , pmisek@jefferies.com

6 Exhibit 3: Quarterly Estimates FQ3E (Nov) FQ4E (Feb) (Feb FY; $B) (Non-GAAP) FY11A Est Street Est Street Revenue Gross Profit GM 44.3% 37.0% 38.6% 36.9% 38.7% SG&A R&D EBITDA EBITDA Margin 25.5% 15.8% 21.7% 15.8% 21.0% EBIT OM 23.3% 12.8% 17.7% 12.9% 16.3% EPS (fd) FQ3E (Nov) FQ4E (Feb) (Feb FY; M) FY11A Est Street Est Street Playbooks Phones ASP (Handset) ASP (Tablet) Net Adds Source: company filings, Jefferies estimates Exhibit 4: Annual Estimates FY12E FY13E (Feb FY; $B) (Non-GAAP) FY11A Est Street Est Street Revenue Gross Profit GM 44.3% 39.2% 39.6% 37.1% 38.4% SG&A R&D EBITDA EBITDA Margin 25.5% 17.1% 21.4% 13.6% 21.1% EBIT OM 23.3% 14.1% 15.7% 10.3% 15.7% EPS (fd) FY12E FY13E (Feb FY; M) FY11A Est Street Est Street Playbooks Phones ASP (Handset) ASP (Tablet) Net Adds (4.0) Source: company filings, Jefferies estimates page 6 of 12 Peter Misek, CFA, CPA, Equity Analyst, (212) , pmisek@jefferies.com

7 Research in Motion Q1 Q2 Q3 Q4 Q1 Q2 Q3E Q4E Q1E Q2E Q3E Q4E FY FY11 FY12E FY13E Income Statement May-10 Aug-10 Nov-10 Feb-11 May-11 Aug-11 Nov-11 Feb-12 May-12 Aug-12 Nov-12 Feb-13 Feb-10 Feb-11 Feb-12 Feb-13 Services and Softw are ,030 1,075 1,030 1,081 1,152 1,066 1,077 1,085 2,417 3,492 4,216 4,380 Devices and Other 3,478 3,779 4,582 4,577 3,878 3,093 3,797 4,011 3,707 3,929 4,278 4,648 12,536 16,416 14,779 16,562 Total Revenue 4,235 4,621 5,495 5,556 4,908 4,168 4,827 5,092 4,859 4,995 5,355 5,733 14,953 19,907 18,994 20,942 Cost Of Goods Sold Services and Softw are Devices and Other 2,202 2,443 2,968 2,960 2,600 2,398 2,891 3,052 2,733 2,888 3,189 3,512 8,019 10,573 10,941 12,321 Cost Of Goods Sold 2,312 2,566 3,101 3,103 2,752 2,556 3,043 3,211 2,958 3,096 3,396 3,720 8,369 11,082 11,563 13,171 Gross Profit 1,923 2,056 2,394 2,453 2,156 1,612 1,783 1,880 1,901 1,899 1,959 2,012 6,584 8,826 7,432 7,771 Selling General & Admin Exp ,811 2,400 2,767 3,243 R & D Exp ,351 1,560 1,686 Amort. of Goodw ill and Intangibles Opex ,138 1,213 1,259 1,205 1,199 1,226 1,306 1,379 1,441 1,490 3,250 4,189 4,888 5,615 Operating Income 1,059 1,082 1,256 1, ,334 4,636 2,544 2,156 Investment Income EBT Excl. Unusual Items 1,068 1,088 1,245 1, ,363 4,644 2,575 2,189 Income Tax Expense , Net Earnings (reported) ,491 3,411 1,992 1,678 Per Share Items Basic EPS Weighted Avg. Basic Shares Out Diluted EPS Diluted EPS (Non-GAAP) Weighted Avg. Diluted Shares Out Source: company data; Jefferies & Company, Inc. estimates page 7 of 12 Peter Misek, CFA, CPA, Equity Analyst, (212) , pmisek@jefferies.com

8 Research in Motion Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3E Q4E Q1E Q2E Q3E Q4E Balance Sheet May-09 Aug-09 Nov-09 Feb-10 May-10 Aug-10 Nov-10 Feb-11 May-11 Aug-11 Nov-11 Feb-12 May-12 Aug-12 Nov-12 Feb-13 ASSETS Cash And Equivalents 1,135 1,083 1,286 1,551 1,850 1,152 1,435 1,791 1, ,221 1,527 1,917 1,747 Short Term Investments Total Cash & ST Investments 1,755 1,664 1,628 1,911 2,348 1,532 1,776 2,121 2,389 1,149 1,097 1,178 1,566 1,889 2,297 2,146 Accounts Receivable 2,338 2,365 2,712 2,594 2,650 3,216 4,101 3,955 3,772 3,571 3,819 3,917 3,738 3,842 4,119 4,410 Other Receivables Total Receivables 2,555 2,613 2,922 2,800 2,786 3,364 4,340 4,279 4,235 4,198 4,297 4,420 4,218 4,336 4,649 4,977 Inventory ,372 1, Deferred Tax Assets, Curr Other Current Assets Total Current Assets 5,349 5,215 5,574 5,813 6,228 1,083 1,183 1,088 1,476 1,973 1,709 1,563 1,377 1,458 1,579 1,712 Net Property, Plant & Equipment 1,509 1,737 1,844 1,957 2,075 2,169 2,343 2,504 2,576 2,699 2,858 3,012 3,154 3,302 3,458 3,608 Long-term Investments Goodw ill Other Intangibles 1,172 1,291 1,359 1,326 1,298 1,421 1,372 1,798 2,164 2,307 2,379 2,296 2,208 2,112 2,010 1,900 Total Assets 8,835 9,224 9,704 10,204 10,683 10,439 12,085 12,875 13,842 13,198 13,285 13,424 13,486 14,070 14,974 15,333 LIABILITIES Accounts Payable & Accrued expenses 2,007 2,002 2,450 2,254 2,308 2,815 3,553 3,343 3,862 3,672 3,478 3,281 3,250 3,401 3,880 3,801 Curr. Income Taxes Payable Unearned Revenue, Current Def. Tax Liability, Curr Other Current Liabilities Total Current Liabilities 2,266 2,167 2,752 2,432 2,521 3,018 3,834 3,630 3,967 3,778 3,590 3,399 3,374 3,531 4,016 3,944 Def. Tax Liability, Non-Curr Other Non-Current Liabilities Total Liabilities 2,347 2,238 2,884 2,602 2, Stock 2,353 2,375 2,350 2,372 2,368 1,989 2,145 2,199 2,202 2,394 2,406 2,418 2,430 2,442 2,454 2,467 Retained Earnings 4,189 4,664 4,564 5,274 5,656 5,027 5,815 6,749 7,444 7,586 7,843 8,154 8,223 8,631 9,031 9,442 Comprehensive Inc. and Other Total Common Equity 6,488 6,987 6,820 7,603 7,999 7,214 8,004 8,938 9,588 9,917 10,192 10,523 10,610 11,036 11,455 11,886 Total Liabilities And Equity 8,835 9,224 9,704 10,204 10,683 10,439 12,085 12,875 13,842 13,976 14,063 14,202 14,264 14,848 15,752 16,111 Source: company data; Jefferies & Company, Inc. estimates page 8 of 12 Peter Misek, CFA, CPA, Equity Analyst, (212) , pmisek@jefferies.com

9 Research in Motion Q1 Q2 Q3 Q4 Q1 Q2 Q3E Q4E Q1E Q2E Q3E Q4E FY10 FY11 FY12E FY13E Cashflow Statement May-10 Aug-10 Nov-10 Feb-11 May-11 Aug-11 Nov-11 Feb-12 May-12 Aug-12 Nov-12 Feb-13 Feb-10 Feb-11 Feb-12 Feb-13 Net Income , , , , ,677.7 Depreciation & Amort Stock-Based Compensation Other Operating Activities (10.2) (24.0) Change in w orking capital (127.5) (224.0) (307.1) (77.0) (723.0) (23.2) (168.3) (991.5) (41.5) 51.2 (160.7) (496.0) (991.5) (160.0) Cash from Ops. 1, , ,020.0 (49.0) , , , , ,230.2 Capital Expenditure (226.1) (208.0) (301.1) (303.8) (222.0) (287.0) (200.9) (198.9) (908.8) (188.9) (198.4) (208.3) (1,009.4) (1,039.0) (908.8) (801.9) Cash Acquisitions (14.1) (318.8) 0 (161.1) (27.0) (103.0) 0 0 (130.0) (143.4) (494.0) (130.0) 0 Sale (Purchase) of Intangible assets (42.4) (104.4) (45.5) (364.7) (560.0) (244.0) (244.0) (30.0) (1,078.0) (30.0) (30.0) (30.0) (421.4) (557.0) (1,078.0) (120.0) Invest. in Marketable & Equity Securt. (103.2) (173.5) 1, (463.0) (14.9) (15.6) (16.4) (17.2) (18.1) , (71.4) Net (Inc.) Dec. in Loans Originated/Sold - - Other Investing Activities - - Cash from Investing (385.8) (88.5) (520.1) (782.0) (1,097.0) (459.8) (244.5) (1,805.9) (235.4) (245.6) (256.4) (1,470.1) (264.5) (1,805.9) (993.3) Long-Term Debt Repaid (6.1) Total Debt Repaid (6.1) Issuance of Common Stock Repurchase of Common Stock (416.9) (1,548.6) (171.1) (16.5) (26.0) (11.0) (200.0) (200.0) (437.0) (389.0) 0 0 (869.5) (2,153.0) (437.0) (389.0) Other Financing Activities (0.6) (0.7) (1.0) (0.4) Cash from Financing (409.0) (1,544.7) (166.0) 32.8 (20.0) (10.0) (188.0) (188.0) (404.4) (376.9) (843.4) (2,086.4) (404.4) (339.7) Foreign Exchange Rate Adj. (29.3) 26.8 (3.3) 21.8 (23.0) (2.0) (6.1) 16.0 (2.0) 0 Net Change in Cash (698.1) , (1,135.0) (66.9) 65.7 (162.2) ,674.0 (162.2) Source: company data; Jefferies & Company, Inc. estimates page 9 of 12 Peter Misek, CFA, CPA, Equity Analyst, (212) , pmisek@jefferies.com

10 Company Description Research in Motion designs, manufactures and markets wireless devices, communications solutions and applications globally. The Company is an innovator in the area of wireless technologies and solutions and provides solutions for wireless connectivity to consumers and enterprises around the world. Analyst Certification I, Peter Misek, CFA, CPA, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in this research report. I, Jason North, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in this research report. I, Billy Kim, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in this research report. As is the case with all Jefferies employees, the analyst(s) responsible for the coverage of the financial instruments discussed in this report receives compensation based in part on the overall performance of the firm, including investment banking income. We seek to update our research as appropriate, but various regulations may prevent us from doing so. Aside from certain industry reports published on a periodic basis, the large majority of reports are published at irregular intervals as appropriate in the analyst's judgement. For Important Disclosure information on companies recommended in this report, please visit our website at Disclosures.action or call Meanings of Jefferies Ratings Buy - Describes stocks that we expect to provide a total return (price appreciation plus yield) of 15% or more within a 12-month period. Hold - Describes stocks that we expect to provide a total return (price appreciation plus yield) of plus 15% or minus 10% within a 12-month period. Underperform - Describes stocks that we expect to provide a total negative return (price appreciation plus yield) of 10% or more within a 12-month period. The expected total return (price appreciation plus yield) for Buy rated stocks with an average stock price consistently below $10 is 20% or more within a 12-month period as these companies are typically more volatile than the overall stock market. For Hold rated stocks with an average stock price consistently below $10, the expected total return (price appreciation plus yield) is plus or minus 20% within a 12-month period. For Underperform rated stocks with an average stock price consistently below $10, the expected total return (price appreciation plus yield) is minus 20% within a 12- month period. NR - The investment rating and price target have been temporarily suspended. Such suspensions are in compliance with applicable regulations and/ or Jefferies policies. CS - Coverage Suspended. Jefferies has suspended coverage of this company. NC - Not covered. Jefferies does not cover this company. Restricted - Describes issuers where, in conjunction with Jefferies engagement in certain transactions, company policy or applicable securities regulations prohibit certain types of communications, including investment recommendations. Monitor - Describes stocks whose company fundamentals and financials are being monitored, and for which no financial projections or opinions on the investment merits of the company are provided. Valuation Methodology Jefferies' methodology for assigning ratings may include the following: market capitalization, maturity, growth/value, volatility and expected total return over the next 12 months. The price targets are based on several methodologies, which may include, but are not restricted to, analyses of market risk, growth rate, revenue stream, discounted cash flow (DCF), EBITDA, EPS, cash flow (CF), free cash flow (FCF), EV/EBITDA, P/E, PE/growth, P/CF, P/FCF, premium (discount)/average group EV/EBITDA, premium (discount)/average group P/E, sum of the parts, net asset value, dividend returns, and return on equity (ROE) over the next 12 months. Risk which may impede the achievement of our Price Target This report was prepared for general circulation and does not provide investment recommendations specific to individual investors. As such, the financial instruments discussed in this report may not be suitable for all investors and investors must make their own investment decisions based upon their specific investment objectives and financial situation utilizing their own financial advisors as they deem necessary. Past performance of the financial instruments recommended in this report should not be taken as an indication or guarantee of future results. The price, value of, and income from, any of the financial instruments mentioned in this report can rise as well as fall and may be affected by changes in economic, financial and political factors. If a financial instrument is denominated in a currency other than the investor's home currency, a change in exchange rates may adversely affect the price of, value of, or income derived from the financial instrument described in this report. In addition, investors in securities such as ADRs, whose values are affected by the currency of the underlying security, effectively assume currency risk. page 10 of 12 Peter Misek, CFA, CPA, Equity Analyst, (212) , pmisek@jefferies.com

11 Other Companies Mentioned in This Report Apple Inc. (AAPL: $413.45, BUY) Dell (DELL: $14.88, HOLD) Hewlett-Packard (HPQ: $22.47, BUY) Motorola Mobility Holdings, Inc. (MMI: $37.82, HOLD) Nokia (NOK1V FH: 3.89, HOLD) ZTE Corporation (763 HK: HK$21.20, BUY) Distribution of Ratings IB Serv./Past 12 Mos. Rating Count Percent Count Percent BUY % % HOLD % % UNDERPERFORM % % Other Important Disclosures Jefferies Equity Research refers to research reports produced by analysts employed by one of the following Jefferies Group, Inc. ( Jefferies ) group companies: United States: Jefferies & Company, Inc., which is an SEC registered firm and a member of FINRA. United Kingdom: Jefferies International Limited, which is authorized and regulated by the Financial Services Authority; registered in England and Wales No ; registered office: Vintners Place, 68 Upper Thames Street, London EC4V 3BJ; telephone +44 (0) ; facsimile +44 (0) Hong Kong: Jefferies Hong Kong Limited, which is licensed by the Securities and Futures Commission of Hong Kong with CE number ATS546; located at Suite 2201, 22nd Floor, Cheung Kong Center, 2 Queen s Road Central, Hong Kong. Singapore: Jefferies Singapore Limited, which is licensed by the Monetary Authority of Singapore; located at 80 Raffles Place #15-20, UOB Plaza 2, Singapore , telephone: Japan: Jefferies (Japan) Limited, Tokyo Branch, which is a securities company registered by the Financial Services Agency of Japan and is a member of the Japan Securities Dealers Association; located at Hibiya Marine Bldg, 3F, Yuraku-cho, Chiyoda-ku, Tokyo ; telephone ; facsimile India: Jefferies India Private Limited, which is licensed by the Securities and Exchange Board of India as a Merchant Banker (INM ) and a Stock Broker with Bombay Stock Exchange Limited (INB ) and National Stock Exchange of India Limited (INB ) in the Capital Market Segment; located at 42/43, 2 North Avenue, Maker Maxity, Bandra-Kurla Complex, Bandra (East) Mumbai , India; Tel page 11 of 12 Peter Misek, CFA, CPA, Equity Analyst, (212) , pmisek@jefferies.com

12 This material has been prepared by Jefferies employing appropriate expertise, and in the belief that it is fair and not misleading. The information set forth herein was obtained from sources believed to be reliable, but has not been independently verified by Jefferies. Therefore, except for any obligation under applicable rules we do not guarantee its accuracy. Additional and supporting information is available upon request. Unless prohibited by the provisions of Regulation S of the U.S. Securities Act of 1933, this material is distributed in the United States ("US"), by Jefferies & Company, Inc., a US-registered broker-dealer, which accepts responsibility for its contents in accordance with the provisions of Rule 15a-6, under the US Securities Exchange Act of Transactions by or on behalf of any US person may only be effected through Jefferies & Company, Inc. In the United Kingdom and European Economic Area this report is issued and/or approved for distribution by Jefferies International Limited and is intended for use only by persons who have, or have been assessed as having, suitable professional experience and expertise, or by persons to whom it can be otherwise lawfully distributed. Jefferies International Limited has adopted a conflicts management policy in connection with the preparation and publication of research, the details of which are available upon request in writing to the Compliance Officer. For Canadian investors, this material is intended for use only by professional or institutional investors. None of the investments or investment services mentioned or described herein is available to other persons or to anyone in Canada who is not a "Designated Institution" as defined by the Securities Act (Ontario). For investors in the Republic of Singapore, this material is provided by Jefferies Singapore Limited pursuant to Regulation 32C of the Financial Advisers Regulations. The material contained in this document is intended solely for accredited, expert or institutional investors, as defined under the Securities and Futures Act (Cap. 289 of Singapore). If there are any matters arising from, or in connection with this material, please contact Jefferies Singapore Limited. In Japan this material is issued and distributed by Jefferies (Japan) Limited to institutional investors only. In Hong Kong, this report is issued and approved by Jefferies Hong Kong Limited and is intended for use only by professional investors as defined in the Hong Kong Securities and Futures Ordinance and its subsidiary legislation. In the Republic of China (Taiwan), this report should not be distributed. In India this report is made available by Jefferies India Private Limited. In Australia this information is issued solely by Jefferies International Limited and is directed solely at wholesale clients within the meaning of the Corporations Act 2001 of Australia (the "Act") in connection with their consideration of any investment or investment service that is the subject of this document. Any offer or issue that is the subject of this document does not require, and this document is not, a disclosure document or product disclosure statement within the meaning of the Act. Jefferies International Limited is authorised and regulated by the Financial Services Authority under the laws of the United Kingdom, which differ from Australian laws. Jefferies International Limited has obtained relief under Australian Securities and Investments Commission Class Order 03/1099, which conditionally exempts it from holding an Australian financial services licence under the Act in respect of the provision of certain financial services to wholesale clients. Recipients of this document in any other jurisdictions should inform themselves about and observe any applicable legal requirements in relation to the receipt of this document. This report is not an offer or solicitation of an offer to buy or sell any security or derivative instrument, or to make any investment. Any opinion or estimate constitutes the preparer's best judgment as of the date of preparation, and is subject to change without notice. Jefferies assumes no obligation to maintain or update this report based on subsequent information and events. Jefferies, its associates or affiliates, and its respective officers, directors, and employees may have long or short positions in, or may buy or sell any of the securities, derivative instruments or other investments mentioned or described herein, either as agent or as principal for their own account. Upon request Jefferies may provide specialized research products or services to certain customers focusing on the prospects for individual covered stocks as compared to other covered stocks over varying time horizons or under differing market conditions. While the views expressed in these situations may not always be directionally consistent with the long-term views expressed in the analyst's published research, the analyst has a reasonable basis and any inconsistencies can be reasonably explained. This material does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Clients should consider whether any advice or recommendation in this report is suitable for their particular circumstances and, if appropriate, seek professional advice, including tax advice. The price and value of the investments referred to herein and the income from them may fluctuate. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur. Fluctuations in exchange rates could have adverse effects on the value or price of, or income derived from, certain investments. This report has been prepared independently of any issuer of securities mentioned herein and not in connection with any proposed offering of securities or as agent of any issuer of securities. None of Jefferies, any of its affiliates or its research analysts has any authority whatsoever to make any representations or warranty on behalf of the issuer(s). Jefferies policy prohibits research personnel from disclosing a recommendation, investment rating, or investment thesis for review by an issuer prior to the publication of a research report containing such rating, recommendation or investment thesis. Any comments or statements made herein are those of the author(s) and may differ from the views of Jefferies. This report may contain information obtained from third parties, including ratings from credit ratings agencies such as Standard & Poor s. Reproduction and distribution of third party content in any form is prohibited except with the prior written permission of the related third party. Third party content providers do not guarantee the accuracy, completeness, timeliness or availability of any information, including ratings, and are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, or for the results obtained from the use of such content. Third party content providers give no express or implied warranties, including, but not limited to, any warranties of merchantability or fitness for a particular purpose or use. Third party content providers shall not be liable for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or profits and opportunity costs) in connection with any use of their content, including ratings. Credit ratings are statements of opinions and are not statements of fact or recommendations to purchase, hold or sell securities. They do not address the suitability of securities or the suitability of securities for investment purposes, and should not be relied on as investment advice. Jefferies research reports are disseminated and available primarily electronically, and, in some cases, in printed form. Electronic research is simultaneously available to all clients. This report or any portion hereof may not be reprinted, sold or redistributed without the written consent of Jefferies. Neither Jefferies nor any officer nor employee of Jefferies accepts any liability whatsoever for any direct, indirect or consequential damages or losses arising from any use of this report or its contents. For Important Disclosure information, please visit our website at or call JEFFERIES 2011 Jefferies Group, Inc. page 12 of 12 Peter Misek, CFA, CPA, Equity Analyst, (212) , pmisek@jefferies.com

Precision Equipment Obstacles for EUVL

Precision Equipment Obstacles for EUVL INDUSTRY NOTE Japan Industrials Obstacles for EUVL Key Takeaway It seems that developing the mirror is one of the major obstacles in realizing EUVL lithography. We also summarize the other obstacles (both

More information

Health Care Facilities

Health Care Facilities Page 1 of 5 INDUSTRY NOTE USA Healthcare Health Care Facilities July 21, 2014 Health Care Facilities Hospital Survey: Inpatient Volumes Were Positive; Expect More Doc Outsourcing Key Takeaway We conducted

More information

Micron Tech. (MU) EQUITY RESEARCH AMERICAS. Moore Stress: Expect DRAM Prices to Continue to Increase. BUY Price target $10.00 Price $9.

Micron Tech. (MU) EQUITY RESEARCH AMERICAS. Moore Stress: Expect DRAM Prices to Continue to Increase. BUY Price target $10.00 Price $9. USA Technology Semiconductors Micron Tech. (MU) Moore Stress: Expect DRAM Prices to Continue to Increase Key Takeaway DRAM spot prices have spiked up 106% and contract prices increased by 30% from their

More information

Biotechnology BIIB/Bioverativ: Filings Reveal Incremental New Info On Hemophilia Spinoff

Biotechnology BIIB/Bioverativ: Filings Reveal Incremental New Info On Hemophilia Spinoff INDUSTRY NOTE USA Healthcare BIIB/Bioverativ: Filings Reveal Incremental New Info On Hemophilia Spinoff Key Takeaway This afternoon the Form 10 for BIIB s proposed hemophilia spinoff Bioverativ was issued,

More information

Major Bulk Commodities: Trends and Outlook

Major Bulk Commodities: Trends and Outlook Major Bulk Commodities: Trends and Outlook June 19, 2013 Christopher LaFemina European Metals and Mining Equity Research US: 212 336 7304 UK: +44 (0)207 029 8131 clafemina@jefferies.com Jefferies LLC Seaborne

More information

Fufeng Group Limited (546 HK) Second Price Increase in Two Months

Fufeng Group Limited (546 HK) Second Price Increase in Two Months COMPANY NOTE China Industrials Chemicals Fufeng Group Limited (546 HK) Second Price Increase in Two Months Key Takeaway Fufeng has adjusted its MSG prices again, the second time since late April. Excluding

More information

Public Service Ent. (PEG) Another Bad Bonus

Public Service Ent. (PEG) Another Bad Bonus COMPANY NOTE USA Energy Electric Utilities Public Service Ent. (PEG) Another Bad Bonus Key Takeaway PEG hosted its investor conference and affirmed 2016 ongoing EPS guidance of $2.80-$3.00 and as a result

More information

Verizon Communications (VZ) ARPA Headwinds Likely to Persist

Verizon Communications (VZ) ARPA Headwinds Likely to Persist COMPANY NOTE USA Telecommunications Telecom Services Verizon Communications (VZ) ARPA Headwinds Likely to Persist Key Takeaway Similar to 3Q, better profitability in both Wireless and Wireline drove a

More information

American Tower (AMT) EQUITY RESEARCH AMERICAS. Strong Execution Continues. BUY Price target $ Price $90.01 COMPANY NOTE.

American Tower (AMT) EQUITY RESEARCH AMERICAS. Strong Execution Continues. BUY Price target $ Price $90.01 COMPANY NOTE. COMPANY NOTE USA Telecommunications Telecom Services American Tower (AMT) Strong Execution Continues Key Takeaway AMT beat on all key financial metrics, with acquisitions and strong organic growth expected

More information

Tullett Prebon (LSE: TLPR LN)

Tullett Prebon (LSE: TLPR LN) December 1, 2008 Financial Services Market Structure & Trading United Kingdom Company Update Rating: Price: Price Target: Bloomberg: BUY 150p 260p LSE: TLPR LN Market Data 52-Week Range: 540p-125p Total

More information

FY3/17 JEF forecast. FY3/17 company forecast. Implied progression

FY3/17 JEF forecast. FY3/17 company forecast. Implied progression INDUSTRY NOTE Japan Financials Financials Today at the Races Key Takeaway Today's runners: Nikkei previewed Q1 FY3/17 banks earnings; Janus reported 2Q16 results slight operating miss with positive flows;

More information

TCL Communication (2618 HK)

TCL Communication (2618 HK) COMPANY NOTE HKG Technology Comm. Equipment TCL Communication (2618 HK) Look Forward to Smartphone Growth Key Takeaway TCL Comm reported Q1 earnings materially below our/consensus expectations due to pricing

More information

Lattice Semiconductor (LSCC) Moore Stress Beneficiary - Takeaways From Management Meetings

Lattice Semiconductor (LSCC) Moore Stress Beneficiary - Takeaways From Management Meetings USA Technology Semiconductors Lattice Semiconductor (LSCC) Moore Stress Beneficiary - Takeaways From Management Meetings Key Takeaway After hosting investor meetings with CFO Joe Bedewi and VP Ops. Doug

More information

Kinross Gold Corp. (KGC)

Kinross Gold Corp. (KGC) COMPANY NOTE USA Natural Resources Metals & Mining Kinross Gold Corp. (KGC) Good Operational Performance, Capex Lowered Key Takeaway Kinross reported adjusted 3Q EPS of $0.10, ahead of our and street s

More information

Computer Services & IT Consulting JPM Card Volume Growth Accelerates

Computer Services & IT Consulting JPM Card Volume Growth Accelerates INDUSTRY NOTE USA Technology JPM Card Volume Growth Accelerates Key Takeaway Earlier, JPM (largest V/MA credit card issuer) reported 2Q16 results. US credit card volume growth accelerated 30 bps to 8.2%

More information

HEG (HEG IN) EQUITY RESEARCH INDIA. Strong Quarter; Raising PT. BUY Price target INR5, (from INR4,400.00) Price INR4,343.

HEG (HEG IN) EQUITY RESEARCH INDIA. Strong Quarter; Raising PT. BUY Price target INR5, (from INR4,400.00) Price INR4,343. COMPANY NOTE India Natural Resources Materials (Steel) HEG (HEG IN) Strong Quarter; Raising PT Key Takeaway HEG reported strong quarter driven by higher realisation of US$14,333/t (vs US $12,500/t JEFe).

More information

American Electric Power (AEP)

American Electric Power (AEP) COMPANY NOTE USA Energy Electric Utilities American Electric Power (AEP) Strong 3Q15 and Increased 2015 Guidance Key Takeaway AEP reported 3Q15 EPS of $1.06, which beat Street expectations of $1.00 and

More information

Stryker Corp. (SYK) EQUITY RESEARCH AMERICAS. Recon Strong in 4Q; Stability Expected for HOLD Price target $ Price $96.

Stryker Corp. (SYK) EQUITY RESEARCH AMERICAS. Recon Strong in 4Q; Stability Expected for HOLD Price target $ Price $96. COMPANY NOTE USA Healthcare Medical Supplies & Devices Stryker Corp. (SYK) Recon Strong in 4Q; Stability Expected for 2016 Key Takeaway SYK 4Q results showed a surge in recon where a good domestic volumes,

More information

Consumer. Nevada Numbers - Average Nevada Income Statements Back To 1991

Consumer. Nevada Numbers - Average Nevada Income Statements Back To 1991 January 30, 2009 Consumer Casinos & Gaming Consumer Nevada Numbers - Average Nevada Income Statements Back To 1991 Investment Summary The enclosed note gives readers a financial snapshot of the typical

More information

Technology EQUITY RESEARCH GLOBAL. PC Hardware: More Headwinds Ahead INDUSTRY NOTE. Hong Kong Technology 11 April 2013

Technology EQUITY RESEARCH GLOBAL. PC Hardware: More Headwinds Ahead INDUSTRY NOTE. Hong Kong Technology 11 April 2013 INDUSTRY NOTE Hong Kong PC Hardware: More Headwinds Ahead Key Takeaway PC market continues to deteriorate with unlikely recovery in C2Q13 before Intel launching Haswell. For Asian PC vendors, we see additional

More information

SanDisk Corporation (SNDK) Moore Stress in Play - Expect Gross Margin Upside, Raise PT to $59

SanDisk Corporation (SNDK) Moore Stress in Play - Expect Gross Margin Upside, Raise PT to $59 COMPANY NOTE USA Technology Semiconductors SanDisk Corporation () Moore Stress in Play - Expect Gross Margin Upside, Raise PT to $59 Key Takeaway We continue to believe Moore Stress is driving industry

More information

Strides Arcolab (STR IN)

Strides Arcolab (STR IN) COMPANY NOTE India Healthcare Pharmaceuticals Strides Arcolab () 1Q18: Weak quarter; Expect recovery ahead Key Takeaway STR reported weak 1Q18 as approval delays, mix and operating leverage drove 700bps

More information

AveXis (AVXS) EQUITY RESEARCH AMERICAS. Survey Says...Parents Would Be Interested In AVXS-101 Pivotal Trial. BUY Price target $50.00 Price $41.

AveXis (AVXS) EQUITY RESEARCH AMERICAS. Survey Says...Parents Would Be Interested In AVXS-101 Pivotal Trial. BUY Price target $50.00 Price $41. COMPANY NOTE USA Healthcare Biotechnology AveXis (AVXS) Survey Says...Parents Would Be Interested In AVXS-101 Pivotal Trial Key Takeaway Since there are investor questions surrounding AVXS' ability to

More information

Galapagos (GLPG NA) EQUITY RESEARCH EUROPE. Cash Burn Aim Unchanged at 1Q; Pipeline On-track; Call to Focus on CF Specifics

Galapagos (GLPG NA) EQUITY RESEARCH EUROPE. Cash Burn Aim Unchanged at 1Q; Pipeline On-track; Call to Focus on CF Specifics Netherlands Healthcare Biotechnology Galapagos (GLPG NA) Cash Burn Aim Unchanged at 1Q; Pipeline On-track; Call to Focus on CF Specifics Key Takeaway 1Q cash burn is as expected and 2018 outlook reiterated

More information

Yamaha Motor (7272 JP)

Yamaha Motor (7272 JP) COMPANY NOTE JPN Industrials Autos & Auto Parts Yamaha Motor (7272 JP) Initiate at Hold: Concern over Declining Competitiveness in Emerging Countries Key Takeaway Investment sentiment for Yamaha would

More information

TCL Communication (2618 HK) Painful transition period. Buy (Maintain) Target Price HK$2.33 Up/downside +28.5% Current price HK$1.

TCL Communication (2618 HK) Painful transition period. Buy (Maintain) Target Price HK$2.33 Up/downside +28.5% Current price HK$1. Securities Analysis (Equity) TCL Communication (218 HK) Painful transition period 1H12 profit warning. TCL Com announced profit warning on 15 Jul and expected to record a significant drop in 2Q12 net profit

More information

America's Car-Mart (CRMT)

America's Car-Mart (CRMT) COMPANY NOTE Target Estimate Change USA Financials Consumer Finance February 20, 2014 America's Car-Mart (CRMT) CRMT 3Q14: Competitive Intensity Leads to Higher Credit Costs Key Takeaway CRMT missed consensus

More information

Semiconductors Weekly: Semis Flat on 6% Cuts - Moore Stress Beneficiaries Outperforming

Semiconductors Weekly: Semis Flat on 6% Cuts - Moore Stress Beneficiaries Outperforming INDUSTRY NOTE USA Weekly: Semis Flat on 6% Cuts - Moore Stress Beneficiaries Outperforming Key Takeaway Data from 37 semiconductor earnings reports shows that at the median, semis lowered 4Q revenue expectations

More information

Trumponomics, The Honma Accord & JGB Bondfire

Trumponomics, The Honma Accord & JGB Bondfire May 2017 Trumponomics, The Honma Accord & JGB Bondfire David Zervos Chief Market Strategist dzervos@jefferies.com +1 212 323 7586 The Trump policy equation Summarizing The Trump Policy Effect On Expected

More information

Metals & Mining Incremental Positives for Iron Ore

Metals & Mining Incremental Positives for Iron Ore INDUSTRY NOTE Global Natural Resources Incremental Positives for Iron Ore Key Takeaway A likely shift in Chinese real estate policy to address under-supply of affordable housing in major cities should

More information

BCD Semiconductor (BCDS)

BCD Semiconductor (BCDS) COMPANY NOTE USA Technology Semiconductors BCD Semiconductor (BCDS) Moore Stress Beneficiary Taking Share - Buy Key Takeaway Q3 EPS beat highlights another quarter of consistent execution and share gains

More information

FLASH Mega Manunggal Company Update 2 April 2018

FLASH Mega Manunggal Company Update 2 April 2018 FLASH Mega Manunggal FLASH Mega Manunggal Mandiri Sekuritas Analyst Audrey Hanzdima +6221 5296 9434 audrey.hanzdima@mandirisek.co.id Adrian Joezer +6221 5296 9415 adrian.joezer@mandirisek.co.id Sector:

More information

Materials (Steel) China s Silicon Price Inflects; Western US/EU Continue Gains

Materials (Steel) China s Silicon Price Inflects; Western US/EU Continue Gains INDUSTRY NOTE USA Industrials China s Silicon Price Inflects; Western US/EU Continue Gains Key Takeaway China s Si metal prices appear to have stabilized and inflected over the past week, an encouraging

More information

Materials (Steel) Scrap Preview: May Momentum Persists on Strong Exports; Up +$25-30/t

Materials (Steel) Scrap Preview: May Momentum Persists on Strong Exports; Up +$25-30/t INDUSTRY NOTE USA Industrials Scrap Preview: May Momentum Persists on Strong Exports; Up +$25-30/t Key Takeaway Recyclers expect May scrap prices to move up +$25-30/t on a) strong export demand/pricing

More information

Dry Bulk Sector Panel

Dry Bulk Sector Panel Capital Link Forum March 12, 2018 Maritime Shipping Dry Bulk Sector Panel Randy Giveans Maritime Shipping Group Head Equity Analyst rgiveans@jefferies.com 713.651.3829 Jefferies LLC Disclaimer: Important

More information

26.0x 19.8x 17.5x 16.5x

26.0x 19.8x 17.5x 16.5x COMPANY NOTE USA Technology Software Citrix (CTXS) Synergy User Conference and Analyst Day Key Takeaway We attended CTXS' annual user conference, Synergy, and Analyst Day in Las Vegas. Although there was

More information

Ferroglobe (GSM) EQUITY RESEARCH AMERICAS

Ferroglobe (GSM) EQUITY RESEARCH AMERICAS COMPANY NOTE USA Industrials Materials (Steel) Ferroglobe (GSM) US Levies 4-135% Preliminary Si Metal Antidumping Duties; Reiterate Buy Key Takeaway The imposition of US Si metal import duties of 4-135%

More information

Vertex (VRTX) EQUITY RESEARCH AMERICAS

Vertex (VRTX) EQUITY RESEARCH AMERICAS COMPANY NOTE USA Healthcare Biotechnology Vertex (VRTX) 3Q16: Next-Gens Good Enough To Proceed, A Meaningful Step Key Takeaway Numbers in line, but 3Q highlighted by both next-gen correctors, despite imperfect

More information

Apple Inc. EQUITY RESEARCH ESTIMATE CHANGE. Buy. AAPL - NASDAQ November 3, Enterprise & Consumer Technology

Apple Inc. EQUITY RESEARCH ESTIMATE CHANGE. Buy. AAPL - NASDAQ November 3, Enterprise & Consumer Technology EQUITY RESEARCH ESTIMATE CHANGE Enterprise & Consumer Technology AAPL - NASDAQ November 3, 2017 Closing Price 11/2/2017 $168.11 Rating: Buy 12-Month Target Price: $193.00 52-Week Range: $104.08 - $169.94

More information

Company Report. TCL Comm (2618 HK) Strong FY15E ahead backed by solid product roadmap in smartphone/wearables/apps/cloud; Reiterate BUY BUY

Company Report. TCL Comm (2618 HK) Strong FY15E ahead backed by solid product roadmap in smartphone/wearables/apps/cloud; Reiterate BUY BUY Company Report China Merchants Securities (HK) Co.Ltd. Hong Kong Equity Research TCL Comm (2618 HK) Strong FY15E ahead backed by solid product roadmap in smartphone/wearables/apps/cloud; Reiterate BUY

More information

Equity Research. Apple Inc. AAPL: T-Mobile And Sprint Sees Strong iphone 7 Preorders. Market Perform. September 13, 2016

Equity Research. Apple Inc. AAPL: T-Mobile And Sprint Sees Strong iphone 7 Preorders. Market Perform. September 13, 2016 September 13, 2016 Equity Research Apple Inc. AAPL: T-Mobile And Sprint Sees Strong iphone 7 Preorders T-Mobile and Sprint announces strong iphone 7 Pre-orders. T-Mobile announced iphone 7 and 7 Plus pre-orders

More information

American Tower Corp. AMT 3Q16 Results: Solid Quarter with a Beat and Raise on EBITDA

American Tower Corp. AMT 3Q16 Results: Solid Quarter with a Beat and Raise on EBITDA EQUITY RESEARCH COMPANY UPDATE October 27, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $130.00 AMT - NYSE $115.67 3-5 Yr. EPS Gr. Rate 20% 52-Wk Range $118.26-$83.07 Shares Outstanding 430.0M

More information

Earnings sustainability and asset quality remain under pressure

Earnings sustainability and asset quality remain under pressure Bank of Chongqing (1963 HK; TP H KD6.85; H OLD) Bank of Chongqing (1963 HK) Equity Research Earnings sustainability and asset quality remain under pressure Huatai Research 30 October 2017 Equity China

More information

The Medicines Company Model Update; Busy Catalyst Calendar Ahead

The Medicines Company Model Update; Busy Catalyst Calendar Ahead EQUITY RESEARCH QUARTERLY UPDATE March 23, 2016 Stock Rating: PERFORM 12-18 mo. Price Target NA MDCO - NASDAQ $31.48 3-5 Yr. EPS Gr. Rate NA 52-Wk Range $43.79-$25.27 Shares Outstanding 68.9M Float 67.1M

More information

Suzuki Motor (7269 JP)

Suzuki Motor (7269 JP) COMPANY NOTE JPN Industrials Autos & Auto Parts Suzuki Motor (7269 JP) Initiate at Hold: Better to Wait for Improved Risk-Reward Timing Key Takeaway Suzuki's fundamentals are strong, even with a tough

More information

CR Lands. Winner of next 5 years, BUY. March 21, 2018 Equity Research. Stock code: 1109.HK Rating: BUY Price target (HK$) 34.74

CR Lands. Winner of next 5 years, BUY. March 21, 2018 Equity Research. Stock code: 1109.HK Rating: BUY Price target (HK$) 34.74 Equity Research Winner of next 5 years, BUY 2017 result: slow growth, but high profitability Revenue slightly improved by 8.5% YoY to HKD 118.5 bn. Thanks to GPM growing by 6.5 pts to 40%, gross profit

More information

AutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016

AutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016 EQUITY RESEARCH QUARTERLY UPDATE September 22, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $900.00 AZO - NYSE $751.45 3-5 Yr. EPS Gr. Rate 14% 52-Wk Range $819.54-$681.01 Shares Outstanding 30.8M

More information

Simmtech (222800) Focus on 2H earnings WHAT S THE STORY?

Simmtech (222800) Focus on 2H earnings WHAT S THE STORY? Company Update Simmtech (222800) Focus on 2H earnings Simmtech yesterday reported disappointing 4Q results, which compels us to cut our 2018 operating profit forecast by 10% to KRW52.9b and 12-month target

More information

ContextVision. Expecting solid results and awaiting progress update on research program

ContextVision. Expecting solid results and awaiting progress update on research program 1Q17 Preview (report due April 27 th ) April 24 th 2017 Share price: NOK 61.75 Target: NOK 100.00 (unchanged) Risk: Medium ContextVision Key share data Sector Reuters Bloomberg Health Care COVI.OL COV

More information

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance RAMCO S HOLD Target Price: Rs 503 Deleveraging story playing out Ramco Cements total debt reduced by a massive Rs 5 bn to Rs 22 bn in FY16. The company generated total EBITDA of Rs 11.5 bn in FY16 and

More information

Software IBM 2Q15: Difficult Software Read Across Due to Secular Challenges

Software IBM 2Q15: Difficult Software Read Across Due to Secular Challenges INDUSTRY NOTE USA Technology IBM 2Q15: Difficult Read Across Due to Secular Challenges Key Takeaway As the third largest vendor in the world, we consider IBM s results a gauge on the industry, though we

More information

STMicroelectronics N.V.

STMicroelectronics N.V. ENN Europe France Semiconductors 11 Aug 2004 Deutsche Bank STMicroelectronics N.V. Reiterate cautious industry stance and lowering price target Recommendation Buy Price at 11 Aug 2004 EUR 13.94 Target

More information

Verizon EQUITY RESEARCH QUARTERLY UPDATE PERFORM. VZ 3Q16 First Look: Mixed Results, Positive Guidance Maintained.

Verizon EQUITY RESEARCH QUARTERLY UPDATE PERFORM. VZ 3Q16 First Look: Mixed Results, Positive Guidance Maintained. EQUITY RESEARCH QUARTERLY UPDATE October 20, 2016 Stock Rating: PERFORM 12-18 mo. Price Target NA VZ - NYSE $50.38 3-5 Yr. EPS Gr. Rate 12% 52-Wk Range $56.95-$43.79 Shares Outstanding 4,085.0M Float 3,758.0M

More information

VIX to Fall; Stocks to Rise; Small to Outperform

VIX to Fall; Stocks to Rise; Small to Outperform RBC Capital Markets, LLC October 14, 2014 VIX to Fall; Stocks to Rise; Small to Outperform Market Delivers Above-Average Returns Following Volatility Spikes Investor concerns regarding global growth have

More information

Manulife Financial Corp.

Manulife Financial Corp. I N S T I T U T I O N A L E Q U I T Y R E S E A R C H Robert Sedran, CFA 1 (416) 594-7874 Robert.Sedran@cibc.com Koki Akala, CFA 1 (416) 956-3723 Koki.Akala@cibc.com Maurissa Bell, CPA, CA 1 (416) 594-7283

More information

Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus May 9 May 10 8:30am TBA NA $0.29

Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus May 9 May 10 8:30am TBA NA $0.29 April 19, 2018 Company Sponsored Research Morning Meeting Note Earnings Preview OTC Markets Group Inc. (OTCM) Equity Research Forecast 10% EPS Growth In 1Q:18, Aided By Lower Taxes; View OTCM As Well Positioned

More information

CalAmp Corp. CAMP - $ NASDAQ Buy

CalAmp Corp. CAMP - $ NASDAQ Buy Scott W. Searle, CFA, (646) 616-2782 ssearle@roth.com Sales (800) 933-6830, Trading (800) 933-6820 COMPANY NOTE EQUITY RESEARCH June 28, 2018 Technology: Communications, Wireless & IoT CalAmp Corp. CAMP

More information

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights AMBUJA S 4 MAY 2017 Quarterly Update HOLD Target Price: Rs 232 Margins to improve from Q2 Q1CY17standalone EBITDA at Rs 4.0 bn was in line withconsensus estimate.volume was up 3% YoY to 6 mnt. Realization

More information

ContextVision. Neutral stance maintained after 3Q. 3Q14 Results analysis November 5 th 2014 Share price: NOK Target: NOK 24.

ContextVision. Neutral stance maintained after 3Q. 3Q14 Results analysis November 5 th 2014 Share price: NOK Target: NOK 24. 3Q14 Results analysis November 5 th 2014 Share price: NOK 22.00 Target: NOK 24.00 Risk: Medium ContextVision Key share data Sector Reuters Bloomberg ContextVision is a market making client of Norne Securities

More information

Darden Restaurants, Inc.

Darden Restaurants, Inc. Darden Restaurants, Inc. DRI: Reports Solid Performance; Expectations Were Pretty High Despite Evidence Segment Is Slowing Our View: We reiterate our OW rating following shares coming under pressure because

More information

Company Report. TCL Comm (2618 HK) NDR takeaways: Conservative shipment outlook; Positive on stable margin NEUTRAL WHAT S NEW N/A.

Company Report. TCL Comm (2618 HK) NDR takeaways: Conservative shipment outlook; Positive on stable margin NEUTRAL WHAT S NEW N/A. Company Report China Merchants Securities (HK) Co., Ltd. Hong Kong Equity Research TCL Comm (2618 HK) NDR takeaways: Conservative shipment outlook; Positive on stable margin Expect FY15E Smartphone/tablets/feature

More information

Neutral (maintained) TCL COMMUNICATION 2618 HK Expect a tough 2016F. Weak 4Q15 results. Tough macro environment in emerging markets the major overhang

Neutral (maintained) TCL COMMUNICATION 2618 HK Expect a tough 2016F. Weak 4Q15 results. Tough macro environment in emerging markets the major overhang TMT MARCH 23, 2016 TCL COMMUNICATION 2618 HK Expect a tough 2016F Weak 4Q15 results Tough macro environment in emerging markets the major overhang Lack of catalysts; maintain Neutral Neutral (maintained)

More information

Anta Sports (2020 HK)

Anta Sports (2020 HK) Equity Research Consumer Discretionary Anta Sports (2020 HK) Buy (maintained) Target price: HK$18.50 Product mix improvement in 4Q15 order book 4Q15 order book kept at low-teen, better product mix Order

More information

KWG. Seeking balance between scale and profitability. March 27, 2018 Equity Research. Stock code: 1813.HK Rating: HOLD Price target (HK$) 12.

KWG. Seeking balance between scale and profitability. March 27, 2018 Equity Research. Stock code: 1813.HK Rating: HOLD Price target (HK$) 12. Equity Research Seeking balance between scale and profitability Downgrade to HOLD and revise down TP to HK$12.50: 2017 result missed our estimation; core net profit dropped by 19% YoY, expansion execution

More information

E-FIT trial results indicate no clinical improvement

E-FIT trial results indicate no clinical improvement NEXSTIM OYJ Medical Technology 3 September 2018 11:44 BST FLASH NOTE Nexstim OYJ (NXTMH-FI) E-FIT trial results indicate no clinical improvement OUTPERFORM Price target 1.23 Price 0.23 KEY TAKEAWAY Today,

More information

ContextVision. Solid 2Q and more details on the contract awaited. August 18 th 2014 Share price: NOK Target: NOK Risk: Medium.

ContextVision. Solid 2Q and more details on the contract awaited. August 18 th 2014 Share price: NOK Target: NOK Risk: Medium. August 18 th 2014 Share price: NOK 21.70 Target: NOK 24.00 Risk: Medium ContextVision Key share data Sector Reuters Bloomberg Health Care COVI.OL COV:NO Market Cap (NOKm) 167.9 Net debt (NOKm) -28.6 EV

More information

SPECULATIVE BUY Target: C$1.40. Event. Impact. Action

SPECULATIVE BUY Target: C$1.40. Event. Impact. Action Daily Letter 1 Intrinsyc Software International Inc. ICS : TSX : C$0.49 SPECULATIVE BUY Target: C$1.40 Peter Misek, CA, CPA, CFA 1.416.869.7920 peter.misek@canaccordadams.com Dushan Batrovic, MBA 1.416.869.7399

More information

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E RAMCO S BUY Target Price: Rs 435 Efforts on cost cutting paying off Q2 EBITDA at Rs 2.8 bn (up 30% YoY) was ahead of our estimates due to lower-than-expected costs. Average costs (excluding freight) declined

More information

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630 1QFY18 Result Update July 28,2017 CMP* (Rs) 208 Bloomberg Ticker CROMPTON IN Market Cap. (Rs bn) 130.6 Free Float (%) 65.6 Shares O/S (mn) 630 Channel De-stocking Impairs Top-line; Recovery Ahead Crompton

More information

LifeVantage Corp. NasdaqCM: LFVN

LifeVantage Corp. NasdaqCM: LFVN LifeVantage Corp. NasdaqCM: LFVN New Products and Valuation Outweigh issues in Japan, reiterate Strong Buy LifeVantage Corp (LFVN) focuses on selling healthy living products through direct selling. They

More information

Maruti Suzuki. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research Healthy operating performance; Accumulate October 28, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs5,860 Target Price Rs6,356 Implied Upside 8.5% Sensex 27,916 Nifty

More information

Leju Holdings (LEJU US)

Leju Holdings (LEJU US) Equity Research Property Leju Holdings (LEJU US) Hold (Initiation) Target price: US$16.00 Fairly valued major real estate services provider; initiate at Hold Major real estate services provider in China

More information

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights JK 20 NOV 2017 Quarterly Update BUY Target Price: Rs 1,220 White cement steals the show JK Cement s (JKCE) Q2FY18 EBITDA at Rs 2.1 bn (up 30% YoY) was higher than our and consensus estimates, mainly due

More information

E 2016E 2017E

E 2016E 2017E November 26, 2015 Sinosoft Technology Group [1297.HK] A beneficiary of establishing carbon trading platform. BUY The development of the sales tax refund system for overseas visitors is in line with Sinosoft

More information

FIRST GLANCE COMMENT. Enbridge Inc. (TSX: ENB; 36.69; NYSE: ENB) Q1/07 Results Generally In Line. Sector Perform Average Risk. Impact Neutral.

FIRST GLANCE COMMENT. Enbridge Inc. (TSX: ENB; 36.69; NYSE: ENB) Q1/07 Results Generally In Line. Sector Perform Average Risk. Impact Neutral. 125 WEEKS 17DEC04-01MAY07 Rel. S&P/TSX COMPOSITE INDEX HI-20MAY05 110.97 110.00 HI/LO DIFF -24.90% 100.00 90.00 40.00 38.00 36.00 34.00 32.00 30.00 28.00 7500 6000 4500 3000 1500 2005 D J F M A M J J A

More information

Anta Sports (2020 HK)

Anta Sports (2020 HK) Equity Research Consumer Discretionary Anta Sports (2020 HK) Buy (maintained) Target price: HK$18.50 Strong FY14 results; order book momentum maintained FY14 results above expectation Net profit jumped

More information

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133 4QFY17 Result Update June 06, 2017 Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133 Mixed Quarterly Performance; Volume to Remain Strong has reported a mixed performance in 4QFY17. Its blended

More information

CEVA Inc. CEVA - $ NASDAQ Buy

CEVA Inc. CEVA - $ NASDAQ Buy Suji Desilva, CFA, (415) 306-5120 sdesilva@roth.com Sales (800) 933-6830, Trading (800) 933-6820 COMPANY NOTE EQUITY RESEARCH August 07, 2018 Semiconductors & IT Hardware CEVA Inc. CEVA - $32.55 - NASDAQ

More information

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Q16 results in line, renewed growth outlook; maintain Buy with target price of HK$20.

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Q16 results in line, renewed growth outlook; maintain Buy with target price of HK$20. Equity Research Information Technology Kingsoft (3888 HK) Buy (maintained) Target price: HK$2.77 2Q16 results in line, renewed growth outlook; maintain Buy with target price of HK$2.77 2Q16 results in

More information

FLASH NOTE EQUITY RESEARCH. OUTPERFORM Price target 6.40 Price Elanix Biotechnologies AG (ELN-DE) Updates from webcast include financial outlook

FLASH NOTE EQUITY RESEARCH. OUTPERFORM Price target 6.40 Price Elanix Biotechnologies AG (ELN-DE) Updates from webcast include financial outlook ELANIX BIOTECHNOLOGIES AG Biotechnology 8 August 2018 09:54 BST FLASH NOTE Elanix Biotechnologies AG (ELN-DE) Updates from webcast include financial outlook OUTPERFORM Price target 6.40 Price 2.72 KEY

More information

Equity Research. Verizon Communications Inc. VZ: Resuming Equity Research Coverage At Outperform. Outperform. October 14, 2016

Equity Research. Verizon Communications Inc. VZ: Resuming Equity Research Coverage At Outperform. Outperform. October 14, 2016 October 14, 2016 Equity Research Verizon Communications Inc. VZ: Resuming Equity Research Coverage At Outperform On August 1, 2016, we suspended equity research coverage on Verizon Communications Inc.

More information

Bharat Petroleum Corporation

Bharat Petroleum Corporation Higher inventory loss drag earnings August 14, 2017 Avishek Datta avishekdatta@plindia.com +91 22 66322254 Rating BUY Price Rs479 Target Price Rs553 Implied Upside 15.4% Sensex 31,449 Nifty 9,794 (Prices

More information

CMP* (Rs) 840 Upside/ (Downside) (%) (2.4) Bloomberg Ticker Market Cap. (Rs bn) 379 Free Float (%) 53 Shares O/S (mn) 451.6

CMP* (Rs) 840 Upside/ (Downside) (%) (2.4) Bloomberg Ticker Market Cap. (Rs bn) 379 Free Float (%) 53 Shares O/S (mn) 451.6 Event Update November 08, 2017 Market Cap. (Rs bn) 379 Free Float (%) 53 Shares O/S (mn) 451.6 USFDA Warning Letter Entails Further Downside Risk to US Biz The US FDA has issued a Warning Letter (WL) to

More information

O'Reilly Automotive, Inc. Quick Read: Weather Likely Weighed Upon Sales a Bit

O'Reilly Automotive, Inc. Quick Read: Weather Likely Weighed Upon Sales a Bit EQUITY RESEARCH QUARTERLY UPDATE July 27, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $300.00 ORLY - NASDAQ $277.51 3-5 Yr. EPS Gr. Rate 18% 52-Wk Range $284.66-$225.12 Shares Outstanding 99.4M

More information

BUY. Suprajit Engineering (SEL) Automobiles

BUY. Suprajit Engineering (SEL) Automobiles Suprajit Engineering (SEL) Automobiles Strong performance. Suprajit Engineering reported a consolidated net profit of `210 mn in 3QFY16, which was 2% higher than our estimates. Phoenix Lamps was consolidated

More information

Verizon EQUITY RESEARCH COMPANY UPDATE PERFORM. Verizon to Acquire Fleetmatics; Smart/Accretive Acquisition. August 1, 2016 COMMUNICATION AND CLOUD

Verizon EQUITY RESEARCH COMPANY UPDATE PERFORM. Verizon to Acquire Fleetmatics; Smart/Accretive Acquisition. August 1, 2016 COMMUNICATION AND CLOUD EQUITY RESEARCH COMPANY UPDATE August 1, 2016 Stock Rating: PERFORM 12-18 mo. Price Target NA VZ - NYSE $55.41 3-5 Yr. EPS Gr. Rate 12% 52-Wk Range $56.95-$38.06 Shares Outstanding 4,085.0M Float 3,758.0M

More information

Goodbaby (1086 HK) Buy (maintained) Target price: HK$ H16 results miss, but margin expansion continues. Equity Research Consumer Discretionary

Goodbaby (1086 HK) Buy (maintained) Target price: HK$ H16 results miss, but margin expansion continues. Equity Research Consumer Discretionary Equity Research Consumer Discretionary Goodbaby (1086 HK) Buy (maintained) Target price: HK$4.20 1H16 results miss, but margin expansion continues Maintain Buy Net profit rose 21% YoY to HK$107m in 1H16,

More information

Silicon Works (108320)

Silicon Works (108320) Earnings Review August 14, 2017 12M rating BUY (Maintain) 12M TP W50,000 from W50,000 Up/downside +44% Stock Data KOSPI (Aug 11, pt) 2,320 Stock price (Aug 11, KRW) 34,700 Market cap (USD mn) 494 Shares

More information

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Strong earnings recovery ahead amid continued revenue momentum; maintain Buy

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Strong earnings recovery ahead amid continued revenue momentum; maintain Buy Equity Research Information Technology Mar 29, 216 Kingsoft (3888 HK) Buy (maintained) Target price: HK$24.7 Strong earnings recovery ahead amid continued revenue momentum; maintain Buy FY1 results in

More information

RMBS ARREARS STATISTICS

RMBS ARREARS STATISTICS RMBS ARREARS STATISTICS Australia (Excluding Non-Capital Market Issuance) At February 9, RMBS Performance Watch Australia at February 9, Australia Prime Standard & Poor's Rating Services Mortgage Performance

More information

Important Notices Disclaimer: This document has been prepared by National Australia Bank Limited ABN 12 004 044 937 AFSL 230686 ( NAB ). Any advice contained in this document has been prepared without

More information

All you need to know about the Golden Cross

All you need to know about the Golden Cross All you need to know about the Golden Cross Golden Cross means market base-building to higher returns A Golden Cross is when the 50-day moving average crosses above the 200-day moving average on the S&P

More information

Jefferies Group Another Hack Attack

Jefferies Group Another Hack Attack EQUITY RESEARCH COMPANY UPDATE November 23, 2011 Stock Rating: PERFORM 12-18 mo. Price Target NA JEF - NYSE $10.06 3- Yr. EPS Gr. Rate NA 2-Wk Range $27.12-$9.0 Shares Outstanding 199.7M Float 148.3M Market

More information

Mahindra & Mahindra. Source: Company Data; PL Research

Mahindra & Mahindra. Source: Company Data; PL Research Tractors drive Q2 performance; Accumulate November 11, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs1,242 Target Price Rs1,503 Implied Upside 21.0% Sensex 26,819 Nifty

More information

KOLAO Holdings ( KS)

KOLAO Holdings ( KS) Company Report (900140 KS) Retail New businesses need to deliver 1Q12 Review: Record earnings and stronger-than-expected margins Based on 1Q preliminary results, continued to set record earnings with revenues

More information

Huiyin Household Ap 1280 HK

Huiyin Household Ap 1280 HK Huiyin Household Ap 1280 HK BUY TARGET HKD2.15 PRIOR TP HKD2.55 CLOSE HKD1.60 CHINA / RETAILING UP/DOWNSIDE +34.4% UNCHANGED HOW WE DIFFER FROM THE STREET BNP Consensus % Diff Target Price (HKD) 2.15 2.43

More information

Crompton Greaves. Looking to exit overseas Power segment! Source: Company Data; PL Research

Crompton Greaves. Looking to exit overseas Power segment! Source: Company Data; PL Research Looking to exit overseas Power segment! May 29, 2015 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs166 Target Price Rs204

More information

CMP* (Rs) 417 Upside/ (Downside) (%) 46 Bloomberg Ticker. SUNP IN Market Cap. (Rs bn) 1,001 Free Float (%) 46 Shares O/S (mn) 2399

CMP* (Rs) 417 Upside/ (Downside) (%) 46 Bloomberg Ticker. SUNP IN Market Cap. (Rs bn) 1,001 Free Float (%) 46 Shares O/S (mn) 2399 Company Update January 22, 2019 Market Cap. (Rs bn) 1,001 Free Float (%) 46 Shares O/S (mn) 2399 Multiple Growth Drivers in Place despite Near-term Headwinds Industries (SUNP) has released an investor

More information

TVS Motors. Source: Company Data; PL Research

TVS Motors. Source: Company Data; PL Research Margins trajectory looking up ; Accumulate November 01, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate Price Rs709

More information

China Renewable Energy Investment Ltd (987_HK)

China Renewable Energy Investment Ltd (987_HK) Wednesday, March 21, 2018 www.evaluateresearch.com Target Price HK$ 0.50 Current Price HK$ 0.23 Upside Potential 117% Market Cap. Shares Outstanding HK$ 525 mn $ 66.90 mn 2,364.7 mn Free Float (FF %) 631.9

More information